Clinical Trials in Tennessee

Showing 2921-2940 of 9,675 trials

Saypha® VOLUME Lidocaine for Midface Augmentation

NCT05386030

The clinical investigation is a randomized, subject- and evaluator-blinded, active treatment controlled, multicenter, clinical investigation, to demonstrate the non inferiority of saypha® VOLUME Lidocaine to one of the devices approved for the same indication (Juvéderm® Voluma™ XC).

Moderate to Severe Midface Volume Deficit

Croma-Pharma GmbH562 participantsStarted Aug 2022

Scottsdale, Arizona, United States • Encino, California, United States • Fremont, California, United States +13 more locations

COMPLETEDNA29 miles

Visualizing Vascular Mechanisms of Salt Sensitivity

NCT03696433

This study aims to assess the salt sensitive blood pressure response to dietary salt load compared with radiological markers of salt handling.

ObesityCardiovascular Risk FactorSalt; Excess

Vanderbilt University Medical Center19 participantsStarted Feb 2019

Nashville, Tennessee, United States

Saypha® VOLUME Lidocaine for Midface Augmentation

Visualizing Vascular Mechanisms of Salt Sensitivity

Find Trials by Condition in Tennessee

A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)

Emergency Department-Initiated Buprenorphine Validation Network Trial

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation

Nemaline Myopathy Clinical Research Network (NM-CTRN)

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Safety and Effectiveness of the Hydrus Microstent

Safety and Efficacy of XT-150 for Facet Joint Osteoarthritis Pain

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer

Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function